Fda Review: Ranbaxy Set to Lose $150m Us Revenue [India Business]
Times of India, The › September 04, 2009
Linked as:
Extract
Fda Review: Ranbaxy Set to Lose $150m Us Revenue [India Business]
NEW DELHI: Nearly 15% of drug exports to US from Ranbaxy may be adversely impacted as a result of the new USFDA action on the company's Paonta Sahib (Himachal Pradesh) facil...
See the full content of this document
Sponsored links
